Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121620) titled 'The Impact of a Low-Dose Esketamine on Sleep Quality Following Cesarean Section' on April 1.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Tianjin Medical University General Hospital, Tianjin, China
Condition:
Postpartum Sleep Disturbance
Intervention:
Esketamine group:After the fetus is delivered during a cesarean section, the patient is slowly intravenously injected with 0.25mg/kg of esketamine diluted with 5ml
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-01
Target Sample Size: Esketamine group:85;Control group:85;
Countries of Recruitme...